Systematic lupus erythematosus prevalence in the U.K.: Methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 2, 2007, Pages 144-151

  Nightingale, A L ^a   Farmer, R D T ^a   de Vries, C S ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

General Practice Research Database; Lupus erythematosus; Methods; Prevalence; Systematic

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIBLIOGRAPHIC DATABASE; CHILD; DISEASE SURVEILLANCE; FEMALE; GENERAL PRACTICE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREND STUDY; UNITED KINGDOM; AGE; CHRONIC DISEASE; EPIDEMIOLOGY; METHODOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RECURRENT DISEASE; REGISTER; STATISTICS; TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; REGISTRIES; RESEARCH DESIGN; SEX FACTORS; TIME FACTORS;

EID: 33847139370     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1253     Document Type: Article

References (19)

1. Barr SG, Zonan-Nacach A, Magder LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999; 42(12): 2682-2688.
2. Garcia Rodriguez LA, Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419-425.
3. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997; 350: 1097-1099.
4. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends 1997; Spring: 36-40.
5. Nightingale AL, Farmer RDT, de Vries CS. Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Safe In print.
6. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK. 1989-1990. Rheumatoloy 1993; 32: 110-115.
7. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Arthritis Rheum 1995; 38(4): 551-558.
8. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus 1997; 6: 399-403.
9. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994; 53: 675-680.
10. Molokhia M, McKeigue PM, Cuadrado M, Hughes G. Systemic lupus erythematosus in migrants from West Africa compared with Afro-Caribbean people in the UK. Lancet 2001; 357: 1414.
11. Samanta A, Roy S, Feehally J, Symmons DPM. The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester City. UK. Br J Rheumatol 1992; 31: 679-682.
12. Tan EM, Cohen AS, Fries AF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25(11): 1271-1277.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40(9): 1725.
14. Petri M. Epidemiology of systemic lupus erythematosus. Best Prac Res Clin Rheumatol 2002; 16(5): 847-858.
15. Lis Y, Mann RD. The VAMP research multi-purpose database in the UK. J Clin Epidemiol 1995; 48(3): 431-433.
16. Robinson D, Schulz E, Brown P, Price C. Updating the Read Codes: user-interactive maintenance in a dynamic clinical vocabulary. J Am Med Inform Assoc 1997; 350: 1097-1099.
17. Lawrenson R, Todd J-C, Leydon GM, Williams TJ, Farmaer RDT. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000; 49: 591-596.
18. Lewis JD, Bresinger C, Bilker WB, Strom BL. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Safe 2002; 11: 211-218.
19. Farrar JT, Mikuls TR, Saag KG, Bilker W, Fernandes S, Strom BL. Issues in the determination of disease prevalence from medical record databases: cumulative incidence in chronic diseases such as gout. Pharmacoepidemiol Drug Safe 2003; 12: S172.